Pioglitazone Regulates Chondrocyte Metabolism and Attenuates Osteoarthritis by Activating Peroxisome Proliferator-Activated Receptor Gamma

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2025 Feb 26

PMID 40008494

Authors

Jiaqi Shi

Tianlun Gong

Yi Zhou

Affiliations

Soon will be listed here.

Abstract

Osteoarthritis presents a significant clinical challenge due to its high prevalence and the resultant impairment of patients' motor function. Osteoarthritic chondrocytes are characterised by inflammation and metabolic disturbances. Pioglitazone, an agonist of peroxisome proliferator-activated receptor γ (PPAR-γ), has been demonstrated to exert anti-inflammatory effects across various diseases. This study aims to investigate the potential protective effects of Pioglitazone on osteoarthritic chondrocytes. An in vitro chondrocyte inflammation model was established utilising IL-1β. The impact of Pioglitazone on chondrocyte inflammation and extracellular matrix synthesis was evaluated through enzyme-linked immunosorbent assay, immunofluorescence staining and Alcian blue staining. The affinity of Pioglitazone for PPAR-γ was investigated using molecular docking techniques. Alterations in chondrocyte glycolysis and oxidative phosphorylation were examined using the Seahorse XF Analyser, and the influence of Pioglitazone on glucose uptake and the mitochondrial electron transport chain was further analysed. Pioglitazone was gavaged in a mouse OA model established by anterior cruciate ligament transection to evaluate the therapeutic efficacy of Pioglitazone. Our findings indicate that Pioglitazone mitigates chondrocyte inflammation and osteoarthritis in murine models by inhibiting the expression of inflammatory mediators such as TNF-α, IL-6 and PGE2, and by preventing the degradation of aggrecan and collagen II. Furthermore, Pioglitazone significantly upregulated the expression of glucose transporter 1 and stabilised the mitochondrial proton delivery chain in a PPAR-γ-dependent manner, thereby enhancing chondrocyte glucose uptake, glycolysis, and oxidative phosphorylation. These effects were partially reversed by the PPAR-γ antagonist GW9662. Pioglitazone can confer chondroprotective benefits in osteoarthritis by activating PPAR-γ.

References

Juel N, Brox J, Hellund J, Holte K, Berg T . The prevalence of radiological glenohumeral osteoarthritis in long-term type 1 diabetes: the Dialong shoulder study. Scand J Rheumatol. 2017; 47(4):325-330. DOI: 10.1080/03009742.2017.1397189. View

Paterson K, Gates L . Clinical Assessment and Management of Foot and Ankle Osteoarthritis: A Review of Current Evidence and Focus on Pharmacological Treatment. Drugs Aging. 2019; 36(3):203-211. DOI: 10.1007/s40266-019-00639-y. View

Hameed F, Ihm J . Injectable medications for osteoarthritis. PM R. 2012; 4(5 Suppl):S75-81. DOI: 10.1016/j.pmrj.2012.02.010. View

Hunter D, Schofield D, Callander E . The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol. 2014; 10(7):437-41. DOI: 10.1038/nrrheum.2014.44. View

Bertholet A, Natale A, Bisignano P, Suzuki J, Fedorenko A, Hamilton J . Mitochondrial uncouplers induce proton leak by activating AAC and UCP1. Nature. 2022; 606(7912):180-187. PMC: 9646675. DOI: 10.1038/s41586-022-04747-5. View

Yu H, Liu Y, Yang X, He J, Zhang F, Zhong Q . Strontium ranelate promotes chondrogenesis through inhibition of the Wnt/β-catenin pathway. Stem Cell Res Ther. 2021; 12(1):296. PMC: 8139050. DOI: 10.1186/s13287-021-02372-z. View

Wang C, Gao Y, Zhang Z, Chen C, Chi Q, Xu K . Ursolic acid protects chondrocytes, exhibits anti-inflammatory properties via regulation of the NF-κB/NLRP3 inflammasome pathway and ameliorates osteoarthritis. Biomed Pharmacother. 2020; 130:110568. DOI: 10.1016/j.biopha.2020.110568. View

Jiang Y . Osteoarthritis year in review 2021: biology. Osteoarthritis Cartilage. 2021; 30(2):207-215. DOI: 10.1016/j.joca.2021.11.009. View

Horvath E, Solyom A, Szekely J, Nagy E, Popoviciu H . Inflammatory and Metabolic Signaling Interfaces of the Hypertrophic and Senescent Chondrocyte Phenotypes Associated with Osteoarthritis. Int J Mol Sci. 2023; 24(22). PMC: 10671750. DOI: 10.3390/ijms242216468. View

10.

Wang X, Liu Z, Deng S, Zhou J, Li X, Huang J . SIRT3 alleviates high glucose-induced chondrocyte injury through the promotion of autophagy and suppression of apoptosis in osteoarthritis progression. Int Immunopharmacol. 2024; 130:111755. DOI: 10.1016/j.intimp.2024.111755. View

11.

Gao M, Chen C, Zhang Q, Bian J, Qin L, Bao L . Research Progress on the Antiosteoarthritic Mechanism of Action of Natural Products. Evid Based Complement Alternat Med. 2021; 2021:7714533. PMC: 8497106. DOI: 10.1155/2021/7714533. View

12.

Lane R, Fu Y, Matsuzaki S, Kinter M, Humphries K, Griffin T . Mitochondrial respiration and redox coupling in articular chondrocytes. Arthritis Res Ther. 2015; 17:54. PMC: 4384316. DOI: 10.1186/s13075-015-0566-9. View

13.

Yan S, Ding J, Wang Z, Zhang F, Li J, Zhang Y . CTRP6 regulates M1 macrophage polarization via the PPAR-γ/NF-κB pathway and reprogramming glycolysis in recurrent spontaneous abortion. Int Immunopharmacol. 2023; 124(Pt A):110840. DOI: 10.1016/j.intimp.2023.110840. View

14.

June R, Liu-Bryan R, Long F, Griffin T . Emerging role of metabolic signaling in synovial joint remodeling and osteoarthritis. J Orthop Res. 2016; 34(12):2048-2058. PMC: 5365077. DOI: 10.1002/jor.23420. View

15.

Du X, Liu Z, Tao X, Mei Y, Zhou D, Cheng K . Research Progress on the Pathogenesis of Knee Osteoarthritis. Orthop Surg. 2023; 15(9):2213-2224. PMC: 10475681. DOI: 10.1111/os.13809. View

16.

Madry H . Surgical therapy in osteoarthritis. Osteoarthritis Cartilage. 2022; 30(8):1019-1034. DOI: 10.1016/j.joca.2022.01.012. View

17.

Choi G, Ju H, Bok J, Choi J, Shin J, Oh H . NRF2 is a spatiotemporal metabolic hub essential for the polyfunctionality of Th2 cells. Proc Natl Acad Sci U S A. 2024; 121(28):e2319994121. PMC: 11252815. DOI: 10.1073/pnas.2319994121. View

18.

Wang L, Zeng N, Yan Z, Li J, Ni G . Post-traumatic osteoarthritis following ACL injury. Arthritis Res Ther. 2020; 22(1):57. PMC: 7092615. DOI: 10.1186/s13075-020-02156-5. View

19.

Hollander J, Zeng L . The Emerging Role of Glucose Metabolism in Cartilage Development. Curr Osteoporos Rep. 2019; 17(2):59-69. PMC: 7716749. DOI: 10.1007/s11914-019-00506-0. View

20.

King K, Findley T, Williams A, Bucknell A . Veterans with diabetes receive arthroplasty more frequently and at a younger age. Clin Orthop Relat Res. 2013; 471(9):3049-54. PMC: 3734424. DOI: 10.1007/s11999-013-3026-3. View